RTW Investments

Rounds

• P Prolium BioscienceLeadClinical-stage biotech developing a CD20xCD3 T-cell engager for autoimmune disease $50MSeries A · 3 Mar
• K Kailera TherapeuticsDevelops injectable and oral GLP-1/GIP obesity drug KAI-9531 $600MSeries B · 14 Oct

No round matches these filters.

Often invests with

• Adage Capital1
• Atlas Venture1
• Bain Capital Private Equity1
• CPP Investments1
• Invus1
• Janus Henderson1